Video, enVista® IOL in Oculocutaneous Albinism Patient

Article

In this educational video, Anil Shivaram, MD of Claremont Eye Associates implants the enVista® IOL from Bausch + Lomb in a patient with type 1 oculocutaneous albinism utilizing the Stellaris® Vision Enhancement System and Storz CapsuleGuard IA handpiece.

In this educational video, Anil Shivaram, MD of Claremont Eye Associates implants the enVista® IOL from Bausch + Lomb in a patient with type 1 oculocutaneous albinism utilizing the Stellaris® Vision Enhancement System and Storz CapsuleGuard IA handpiece.  

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
ChatGPT may have a future use in glaucoma

ChatGPT may have a future use in glaucoma

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Podcast
Therapeutic in development to take on diabetic macular edema

Therapeutic in development to take on diabetic macular edema

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention

Podcast
Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Article
Stress resilience–enhancing drugs: New class of small molecules holds promise

Stress resilience–enhancing drugs: New class of small molecules holds promise

Article
© 2024 MJH Life Sciences

All rights reserved.